Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

Published:2010-10 Issue:4 Volume:160 Page:635-641.e2
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Ruff Christian T.,Giugliano Robert P.,Antman Elliott M.,Crugnale Sharon E.,Bocanegra Tomas,Mercuri Michele,Hanyok James,Patel Indravadan,Shi Minggao,Salazar Dan,McCabe Carolyn H.,Braunwald Eugene

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study;Go;JAMA,2001

3. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study);Furberg;Am J Cardiol,1994

4. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention;Hart;Ann Intern Med,1999

5. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

Cited by 427 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation;JAMA Cardiology;2024-09-01

2. Crosslink between atrial fibrillation and cancer: a therapeutic conundrum;Cardio-Oncology;2024-08-07

3. Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation;Circulation: Cardiovascular Quality and Outcomes;2024-07

4. A Common Data Model for Oral Anticoagulants-related Risk of Spontaneous Intracranial Hemorrhage (Preprint);2024-05-01

5. The Impacts of Oral Anticoagulants on Clinical Outcomes in Patients with Atrial Fibrillation Across Five Stages of Renal Function;2024-04-16